Search results
Results From The WOW.Com Content Network
National Donor Deferral Registry. The National Donor Deferral Registry, also known as the (NDDR) is a database of individuals who have tested "reactive" for viral agents like human immunodeficiency viruses (HIV), Hepatitis B virus (HBV), and hepatitis C virus (HCV) and are permanently prohibited from donating plasma. [ 1]
Grifols. Grifols, S.A. ( Catalan: [ˈɡɾifuls]) is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma –based products, a field in which it is the European leader and largest worldwide, [ 3][ 4] the company also supplies devices, instruments, and reagents for clinical testing laboratories .
The United Network for Organ Sharing ( UNOS) is a non-profit scientific and educational organization that administers the only Organ Procurement and Transplantation Network ( OPTN) in the United States, established ( 42 U.S.C. § 274) by the U.S. Congress in 1984 by Gene A. Pierce, founder of United Network for Organ Sharing.
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
Vitalant (formerly Blood Systems Inc.[ 1]) is a nonprofit organization that collects blood from volunteer donors and provides blood, blood products and services across the United States. It was founded in 1943 as the Salt River Valley Blood Bank in Phoenix, Arizona . Vitalant is the nation’s largest independent, nonprofit blood services ...
Brittney Griner Reveals Why She Teared Up During National Anthem After Winning Gold: 'My Country Fought for Me to Get Back'
The National Marrow Donor Program (NMDP) is a nonprofit organization founded in 1987 and based in Minneapolis, Minnesota, that operates the Be The Match Registry of volunteer hematopoietic cell donors and umbilical cord blood units in the United States . The Be The Match Registry is the world's largest hematopoietic cell registry, listing more ...
July 24, 2024 at 4:12 AM. (Reuters) -Pfizer's gene therapy for hemophilia A significantly cut the number of annual bleeding episodes in patients with the rare disorder in a late-stage study and ...